Last reviewed · How we verify

NCT07258732: PROBE

The Impact of Probiotics on Bariatric Treatment Outcomes

Active, enrolled NA Last updated 2 December 2025
What this trial tests

NA trial testing Probiotic in Obesity &Amp; Overweight in 200 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
10 July 2025
Primary endpoint
10 July 2026
31 December 2026

Quick facts

Lead sponsorUniversity of Warmia and Mazury in Olsztyn
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment200
Start date10 July 2025
Primary completion10 July 2026
Estimated completion31 December 2026
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University of Warmia and Mazury in Olsztyn

Who can join

18 and older, any sex, with Obesity &Amp; Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The planned study aims to assess whether probiotics improve the quality of life in patients during the early postoperative period following sleeve gastrectomy, and whether they influence the absorption of micro- and macronutrients. Patients eligible for inclusion will have a BMI of 40 kg/m² or higher and must have successfully completed the qualification process for sleeve gastrectomy. Exclusion criteria include chronic gastrointestinal diseases, antibiotic use within 4 weeks prior to surgery, and lack of consent to participate in the study. On the day before surgery, a stool sample will be collected from each patient for microbiological analysis to assess the composition of gut bacteria. Patients will then undergo sleeve gastrectomy using a standard surgical technique. After the operation, participants will be randomized into two groups. The first group will receive probiotics containing Bifidobacterium animalis AMT30, Bifidobacterium breve AMT32, and Lactobacillus plantarum AMT14. These strains are deposited in the Polish Collection of Microorganisms at the Polish Academy of Sciences in Wrocław and are protected by Polish, European, and U.S. patents. The second group will receive a placebo. As part of follow-up, stool samples will be collected again one month and three months after surgery for comparative microbiological analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Obesity &Amp; Overweight

Currently open trials in the same condition.

Other University of Warmia and Mazury in Olsztyn trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07258732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing